Online citations, reference lists, and bibliographies.
← Back to Search

Alteration In A New Gene Encoding A Putative Membrane-organizing Protein Causes Neuro-fibromatosis Type 2

G. Rouleau, P. Mérel, M. Lutchman, M. Sanson, J. Zucman, C. Marineau, K. Hoang-Xuan, S. Demczuk, C. Desmaze, B. Plougastel, S. Pulst, G. Lenoir, E. Bijlsma, Raimund Fashold, J. Dumanski, P. Jong, D. Parry, Roswell Eldrige, A. Aurias, O. Delattre, G. Thomas
Published 1993 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Neurofibromatosis type 2 (NF2) is a monogenic dominantly inherited disease predisposing carriers to develop nervous system tumours. To identify the genetic defect, the region between two flanking polymorphic markers on chromosome 22 was cloned and several genes identified. One is the site of germ-line mutations in NF2 patients and of somatic mutations in NF2-related tumours. Its deduced product has homology with proteins at the plasma membrane and cytoskeleton Interface, a previously unknown site of action of tumour suppressor genes in humans.
This paper references
10.1128/MCB.12.9.4242
Translation of the rat LINE bicistronic RNAs in vitro involves ribosomal reinitiation instead of frameshifting.
H. Ilves (1992)
10.1002/GCC.2870050402
Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints
J. Zucman (1992)
10.1016/0165-4608(89)90192-1
A cytogenetic study of 53 human gliomas.
R. Jenkins (1989)
10.1016/0888-7543(91)90366-M
Mapping of human chromosome 22 with a panel of somatic cell hybrids.
O. Delattre (1991)
10.1136/jmg.29.12.841
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.
D. Evans (1992)
10.1002/GCC.2870050105
Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors
C. Desmaze (1992)
Neurofibromatosis type 2 appears to be a genetically homogeneous disease.
S. Narod (1992)
10.1016/0888-7543(91)90513-E
Parental origin of chromosome 22 loss in sporadic and NF2 neuromas.
B. Fontaine (1991)
10.1056/NEJM198803173181106
Neurofibromatosis 2 (bilateral acoustic neurofibromatosis).
R. Martuza (1988)
10.1016/0165-4608(90)90066-J
Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analyses.
J. Couturier (1990)
10.1038/327336A0
Use of restriction enzymes to detect potential gene sequences in mammalian DNA
S. Lindsay (1987)
10.1002/j.1460-2075.1989.tb08598.x
cDNA cloning and sequencing of the protein‐tyrosine kinase substrate, ezrin, reveals homology to band 4.1.
K. L. Gould (1989)
Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization.
O. Turunen (1989)
10.1038/347685A0
Sequence and domain structure of talin
D. G. Rees (1990)
10.1093/NAR/13.9.3131
Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis.
R. Myers (1985)
10.1002/GCC.2870050416
Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma
Norifumi Tanaka (1992)
10.1017/S0022215100147292
Epidemiology of acoustic neuromas.
M. Tos (1984)
10.1073/PNAS.84.24.9275
Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma.
J. Dumanski (1987)
10.1016/0378-1119(84)90153-7
Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.
S. Henikoff (1984)
Molecular genetic analysis of chromosome 22 in 81 cases of meningioma.
J. Dumanski (1990)
10.1016/0092-8674(87)90534-4
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene
B. R. Seizinger (1987)
10.1073/PNAS.88.19.8297
Moesin: a member of the protein 4.1-talin-ezrin family of proteins.
W. Lankes (1991)
10.1093/NAR/19.20.5805-A
CA repeat polymorphism at the D5S299 locus linked to adenomatous polyposis coli (APC).
C. van Leeuwen (1991)
10.1038/359162A0
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
O. Delattre (1992)
10.1016/S0022-2836(05)80360-2
Basic local alignment search tool.
S. Altschul (1990)
10.1038/332644A0
Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
M. Whitman (1988)
10.1002/GCC.2870050305
Molecular characterization of chromosome 22 deletions in schwannomas
E. Bijlsma (1992)
Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene.
S. Olschwang (1993)
10.1093/NAR/20.3.642-A
A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene.
L. Spirio (1991)
10.1016/0076-6879(87)55032-7
Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis.
L. Lerman (1987)
10.1002/j.1460-2075.1988.tb03032.x
The structure and organization of the human heavy neurofilament subunit (NF‐H) and the gene encoding it.
J. F. Lees (1988)
10.1038/329246A0
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22
G. Rouleau (1987)
10.1073/PNAS.84.15.5419
Molecular genetic approach to human meningioma: loss of genes on chromosome 22.
B. Seizinger (1987)
10.1126/SCIENCE.3107130
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.
D. Barker (1987)
10.1038/322644A0
Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma
B. Seizinger (1986)
10.1038/331273A0
Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli
M. Okamoto (1988)
10.1073/PNAS.83.24.9512
Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton.
J. Conboy (1986)
10.1073/PNAS.88.14.5949
Isolation of a cDNA clone encoding a human protein-tyrosine phosphatase with homology to the cytoskeletal-associated proteins band 4.1, ezrin, and talin.
Q. Yang (1991)
Molecular Cloning: A Laboratory Manual
J. Sambrook (1983)



This paper is referenced by
Advances in Brief NeurofÃ-bromatosis Type 2 ( NF 2 ) Gene Is Somatically Mutated in Mesothelioma but not in Lung Cancer 1
Yoshitaka (2006)
10.1016/S0065-230X(08)60860-X
Cytogenetics and molecular genetics of bone and soft tissue tumors.
N. Mandahl (1996)
10.1002/lary.24564
The role of vascular endothelial growth factor and vascular stability in diseases of the ear
N. London (2014)
10.2336/NISHINIHONHIFU.59.402
Cell adhesion molecule and membrane lining protein of epidermal keratinocyte (3). Relationship between roles in the intracellular information transfer mechanisms and differentiation, growth and canceration.
T. Hashimoto (1997)
10.1139/O97-078
Characterization of a cDNA encoding a novel band 4.1-like protein in zebrafish.
G. M. Kelly (1997)
10.1002/cphg.36
Overview of Genetic Diagnosis in Cancer
B. Korf (2017)
CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.
L. Sherman (1997)
10.1083/JCB.140.3.647
Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association
T. Matsui (1998)
10.1002/(SICI)1097-0169(1999)42:3<178::AID-CM2>3.0.CO;2-3
Activities of the EM10 protein from Echinococcus multilocularis in cultured mammalian cells demonstrate functional relationships to ERM family members.
K. Hubert (1999)
10.1002/(SICI)1096-8628(19990326)89:13.0.CO;2-I
Neurofibromatosis 1. Introduction.
D. Viskochil (1999)
10.1091/MBC.9.2.403
RhoA-dependent phosphorylation and relocalization of ERM proteins into apical membrane/actin protrusions in fibroblasts.
R. Shaw (1998)
10.1002/cncr.11275
Quinidine impairs proliferation of neurofibromatosis type 2‐deficient human malignant mesothelioma cells
T. Utermark (2003)
10.1177/002215549904701113
Expression of the Neurofibromatosis Type 2 Gene in Human Tissues
M. Bakker (1999)
10.1097/01.mao.0000180484.24242.54
The Molecular Biology of Vestibular Schwannomas: Dissecting the Pathogenic Process at the Molecular Level
B. Neff (2006)
10.1016/J.SPEN.2006.01.007
The genetic and molecular pathogenesis of NF1 and NF2.
K. Yohay (2006)
10.1007/978-1-4939-1830-0_1
Hereditary Predisposition to Primary CNS Tumors
Uri Tabori (2015)
10.1017/S0317167100005357
Purification of the NF2 tumor suppressor protein from human erythrocytes.
H. Jindal (2006)
10.1038/sj.onc.1210988
Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton
M. Laulajainen (2008)
10.1016/S0246-0378(09)46751-4
Neurofibromatose de type 2
S. Goutagny (2009)
10.1093/jb/mvr021
Mammalian Hippo pathway: from development to cancer and beyond.
Yijun Bao (2011)
Sodium butyrate modulates pRb phosphorylation and induces cell death in human vestibular schwannomas in vitro.
Rohan Mitra (2012)
10.1016/j.nicl.2013.12.010
Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2☆
W. Vargas (2014)
10.1097/SCS.0b013e318210bb2f
Tongue Schwannoma: Clinicopathological Findings
Luciano Catalfamo (2011)
10.1093/neuonc/not165
A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma.
I. Zemmoura (2014)
10.1136/jmg.33.1.2
Molecular genetics of neurofibromatosis type 1 (NF1).
M. H. Shen (1996)
10.1023/A:1006414405305
Intramedullary Ependymomas: Clinical Presentation, Surgical Treatment Strategies and Prognosis
T. Schwartz (2004)
10.1007/s100720050017
The neurofibromatoses. An overview
M. Ruggieri (1999)
10.1385/NMM:8:1-2:191
Role of integrins in periphral nerves and hereditary neuropathies
C. Berti (2007)
10.1016/j.braindev.2013.01.007
Characterization of early onset neurofibromatosis type 2
M. Matsuo (2014)
10.3171/jns.2003.99.3.0480
Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2.
G. Otsuka (2003)
In Search of High-Penetrant Hereditary Prostate Cancer Susceptibility Genes
A. Rökman (2004)
The tumor suppressor gene , lethal ( 2 ) giant larvae ( l ( 2 ) gl ) , is required for cell shape change of epithelial cells during Drosophila development
P. Manfruelli (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar